Superior HealthPlan Introduces Assessment Tool to Connect Texans with Community Support

Superior HealthPlan, a prominent managed care organization in Texas and part of Centene Corporation (NYSE: CNC), has launched a new screening tool designed to help Texans access community resources more easily. This assessment focuses on non-medical drivers of health—barriers that…

Read MoreSuperior HealthPlan Introduces Assessment Tool to Connect Texans with Community Support

Centene’s Health Net Awarded California Medicaid Dental Contract for LA and Sacramento

Centene Corporation (NYSE: CNC), a prominent healthcare enterprise dedicated to enhancing health outcomes, announced that its subsidiary, Health Net Community Solutions, has been chosen by the California Department of Health Care Services to provide managed dental care services to Medi-Cal…

Read MoreCentene’s Health Net Awarded California Medicaid Dental Contract for LA and Sacramento

Varian Partners with Ballad Health for 10-Year Oncology Initiative in Rural Areas

Varian, a Siemens Healthineers company, has announced a 10-year agreement with Ballad Health to enhance oncology treatment services for patients in rural communities across the Appalachian Highlands, including Northeast Tennessee, Southwest Virginia, northwestern North Carolina, and southeastern Kentucky. This transformative…

Read MoreVarian Partners with Ballad Health for 10-Year Oncology Initiative in Rural Areas

CVS Health® Prepares to Support Customers and Colleagues as Hurricane Helene Approaches

CVS Health® (NYSE: CVS) is proactively preparing for the impending landfall of Hurricane Helene in Florida. The company prioritizes the health and safety of its customers, members, and employees, aiming to provide communities with essential products and services ahead of…

Read MoreCVS Health® Prepares to Support Customers and Colleagues as Hurricane Helene Approaches

Estrella Immunopharma’s ARTEMIS® T-Cell Therapy Leads to Complete Remission in First Patient

Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW), a clinical-stage biopharmaceutical company specializing in ARTEMIS® T-cell therapies targeting CD19 and CD22 for cancer and autoimmune disease treatment, has announced that the first patient in the Phase I/II STARLIGHT-1 clinical trial achieved complete…

Read MoreEstrella Immunopharma’s ARTEMIS® T-Cell Therapy Leads to Complete Remission in First Patient

Iambic Therapeutics Recognized in Endpoints 11 Most Promising Biotech Startups

Iambic Therapeutics, a clinical-stage biotech company harnessing its AI-driven discovery platform, has been named to the 2024 Endpoints News list of “Biotech’s Most Promising Startups.” This annual award highlights innovative life science companies working to develop breakthrough therapies. “By integrating…

Read MoreIambic Therapeutics Recognized in Endpoints 11 Most Promising Biotech Startups

Bristol Myers Squibb Unveils Sotyktu Efficacy Data for Scalp Psoriasis in Two Trials

Bristol Myers Squibb (NYSE:BMY) has announced promising results from the Phase 3b/4 PSORIATYK SCALP trial, which assessed the efficacy of Sotyktu (deucravacitinib) in treating patients with moderate-to-severe scalp psoriasis, including those with less extensive psoriasis. The trial met its primary…

Read MoreBristol Myers Squibb Unveils Sotyktu Efficacy Data for Scalp Psoriasis in Two Trials

Naveris Unveils NavDx® Test Data for HPV-Linked Oropharyngeal Cancer at 2024 AAO-HNS Meeting

Naveris, Inc., a leader in precision oncology diagnostics for viral-induced cancers, announced new data presentation at the 2024 Annual Meeting of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), held from September 28 to October 1, 2024, in Miami…

Read MoreNaveris Unveils NavDx® Test Data for HPV-Linked Oropharyngeal Cancer at 2024 AAO-HNS Meeting